Who are the winners & losers in the quantum future

Bernstein says quantum computing is unlikely to have a single winner, with superconducting, trapped-ion and neutral-atom approaches each retaining advantages, and pegs meaningful commercial value creation around 2030. The firm estimates a $90 billion to $170 billion annual TAM by 2040, or about $26.6 billion present value discounted to 2026, and calculates implied market shares of 11% for IonQ, 5% for D-Wave Quantum, 4% for Rigetti, 2% for Xanadu, 2% for Infleqtion and 1% for Quantum Computing. Bernstein also rates IBM at $280 and Infineon at €74, highlighting them as key enablers in the hybrid quantum-classical ecosystem.

Analysis

The market is still pricing quantum as a binary winner-take-all platform race, but the economics here point to a more familiar hardware/software stack outcome: value accrues first to the enabling layer, not the eventual standards winner. That makes IBM the cleaner long-duration compounder than the pure-plays, because hybrid orchestration, workflow integration, and enterprise distribution should monetize earlier than fault-tolerant hardware. The other structural beneficiary is the semiconductor supply chain, especially high-end fabs and specialty process players, since the bottleneck is less “algorithms” than manufacturing yield, cryogenic control, photonics, and packaging.

The current public pure-play valuations already embed meaningful probability of success well before commercial usefulness is visible, which creates a classic duration mismatch. These names can keep rerating on financing access and headline partnerships for years, but the next real inflection likely comes when capex intensity, dilution, and customer patience start to matter more than roadmap narratives. That makes the risk asymmetrical to the downside if 2026-2028 revenue ramps disappoint versus lofty estimates, because the market is already discounting a sizable share of a market that may not be monetizable until the early 2030s.

The contrarian angle is that the biggest upside surprise may come from larger incumbents capturing the “picks and shovels” layer rather than from modality winners. GOOGL remains underappreciated as a long-horizon optionality holder, but it is too far from monetization to be a near-term catalyst. On the downside, any negative signal on technical milestones, funding rounds, or enterprise adoption could reprice the small-cap names sharply in days, while the industrial and semiconductor beneficiaries should trade more on incremental order flow over months rather than on quantum headlines alone.

Key Decisions for Investors

• Long IBM / short a basket of IONQ, QBTS, and QUBT for 3-6 months: express the view that hybrid systems monetize earlier than standalone pure-plays; target 20-30% relative downside in the basket if revenue delivery slips.
• Buy LEAPS on IBM or call spreads into any weakness over the next 1-2 quarters: limited downside, with upside tied to enterprise adoption and re-rating of the hybrid quantum narrative.
• Long NVDA / AVGO / TSM as a second-order supply-chain basket over 6-12 months: if quantum capex accelerates, these names capture tooling, packaging, and high-end compute spend without modality risk; use as lower-volatility exposure to the theme.
• Avoid outright longs in the smaller pure-plays at current levels unless using defined-risk options: the implied commercialization timeline is longer than current valuations justify, so dilution or guidance misses can overwhelm partnership headlines.
• For a tactical event-driven trade, sell upside into partner-announcement spikes in IONQ or QBTS and hedge with small long IBM exposure: this harvests speculative premium while keeping exposure to sector-wide validation.